Abstract
Topical calcineurin inhibitors in cutaneous lupus erythematosusIn the management of cutaneous lupus erythematosus (CLE), topical calcineurin inhibitors have recently been established as the first-line treatment according to the S2k guidelines...
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have